Prestige Consumer Healthcare Inc. (PBH) Social Stream
Prestige Consumer Healthcare Inc (PBH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PBH.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PBH's average price target has moved up $3 over the prior 26 weeks.
Over the past 44 weeks, PBH's average upside potential has been 7.07%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PBH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PBH's average broker recommendation rating worsened by 0.33 over the prior 123 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PBH as an investment opportunity.
- PBH has a lower variance in analysts' estimates than 85.28% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Prestige Consumer Healthcare Inc's upside potential (average analyst target price relative to current price) is greater than 16.47% of them.
- Prestige Consumer Healthcare Inc's number of analysts covering the stock is higher than 31.5% of stocks in the mid market cap category.
- PBH has a higher average analyst price target than 152.54% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Prestige Consumer Healthcare Inc are PAHC, ORGO, and OPK.
What is the outlook for PBH? Use POWR Ratings for clearer insight into price direction.